angel7
06-12-2002, 12:28 PM
"The results build on previously reported data from an animal model of rheumatoid arthritis (RA) suggesting that an inhibitor of Cathepsin S offers a novel approach to the treatment of both MS and RA," Medivir said in a press release.
Piir said the research would now focus on finding a
candidate drug--a molecule which is suitable for developing a drug from the cathepsin S inhibitors.
Piir said the research would now focus on finding a
candidate drug--a molecule which is suitable for developing a drug from the cathepsin S inhibitors.